Drug-Coated Stent Competition Unlikely To Immediately Lower Prices – Cordis

The Centers for Medicare & Medicaid Services should increase the price difference between drug-eluting and bare-metal stents to $3,024 - $1,539 more than the rate suggested in the hospital IPPS proposed rule, according to Johnson & Johnson/Cordis

More from Archive

More from Medtech Insight